Brief: SeaStar Medical Q3 EPS USD -0.13
13/11/2025 21:05
Nov 13 (Reuters) - SeaStar Medical Q3 operating expenses USD 3.748 million. Q3 operating income USD -3.579 million Q3 net income USD -3.472 million
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview